Ayala Pharmaceuticals, Inc. ADXS OTC

Other OTC • Healthcare • Biotechnology • US • USD

Ayala Pharmaceuticals, Inc. (ADXS) — Analyst outlook / Analyst consensus target is. Based on 8 analyst ratings, the consensus is bullish — 6 Buy, 2 Hold.

ADXS Analyst Ratings

Buy

Ratings

6 Buy

2 Hold

Based on 8 analysts giving stock ratings to Ayala Pharmaceuticals, Inc. in the past 3 months

Rating breakdown

Buy

6 75%

Hold

2 25%

75%

Buy

6 analysts

25%

Hold

2 analysts

Sell

0 analysts

People Also View

Onconova Therapeutics, Inc.

$1.00

-0.47%

AEZS

Aeterna Zentaris Inc.

$5.72

+2.14%

ADMP

Adamis Pharmaceuticals Corporation

$0.78

+0.85%

GHSI

Guardion Health Sciences, Inc.

$3.25

+0.93%

LLY

Eli Lilly and Company

Ayala Pharmaceuticals, Inc. ADXS OTC

ADXS Analyst Ratings

People Also View

Get Undervalued Stock Alerts